CEO: | Richard J Marsden |
CFO & Executive Director: | Joseph Colliver |
Chief Scientific Officer: | Phillip David Monk |
Independent Non-Executive Director: | Amanda Radford |
Independent Non-Executive Director: | Bruce Campbell |
Independent Non-Executive Director: | Stephen T Holgate |
Non-Executive Chairman: | Simon J B Shaw |
Non-Executive Dir: | Felicity Gabbay |
Address: | Mailpoint 810, Southampton General Hospital, Tremona Road, Southampton, United Kingdom, SO16 6YD |
Phone: | 44 (0) 23 8051 2800 |
Fax: | 44 (0)23 8051 2800 |
Website: | http://www.synairgen.com |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00B0381Z20 |
Currency | UK Pounds |
Share Price | 6.62p |
Change Today | 0.76p |
% Change | 12.97 % |
52 Week High | 9.80 |
52 Week Low | 4.88 |
Volume | 273,491 |
Shares Issued | 201.37m |
Market Cap | £13.33m |
RiskGrade | 510 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 0 |
Buy | 0 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
Time | Volume / Share Price |
16:29 | 2,308 @ 6.93p |
16:27 | 43,593 @ 6.86p |
15:50 | 38,000 @ 6.50p |
15:50 | 8,000 @ 6.50p |
15:50 | 30,000 @ 6.50p |
You are here: research